The income statement (statement of earnings) reports on the performance of Eli Lilly & Co., the result of its operating activities.
The assets reports major classes and amounts of resources owned or controlled by Eli Lilly & Co..
The liabilities and stockholders' equity reports major classes and amounts of external claims on assets and owners' capital contributions, and other internally generated sources of capital.
The cash flow statement provides information about Eli Lilly & Co.'s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on Eli Lilly & Co.'s statement of financial position.
Common-Size Financial Statements
Income statement components (revenuess and expenses) shown as percentage of total sales.
Assets components shown as percentage of total assets.
Liabilities and stockholders' equity components shown as percentage of total liabilities and stockholders' equity.
Evaluates revenues and output generated by the Eli Lilly & Co.'s assets. Operating performance ratios describe the relationship between the Eli Lilly & Co.'s level of operations and the assets needed to sustain operating activities.
Relative valuation technique determine the value of Eli Lilly & Co. by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock's value, such as earnings, book value, and sales.